Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly EBT Margin of 27.99% for Q1 2026, up 4022.0% year-over-year from 0.68% in Q1 2025, and up 60.85% quarter-over-quarter from 17.4% in Q4 2025.
Jazz Pharmaceuticals (JAZZ) EBT Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 27.99% for Q1 2026.
- In Q1 2026, EBT Margin rose 4022.0% year-over-year to 27.99%; the TTM figure through Mar 2026 stood at 4.93% (down 1384.0% YoY), while the FY2025 annual figure was 14.71%, down 2627.0% from the prior year.
- EBT Margin for Q1 2026 stood at 27.99%, up from 17.4% in the prior quarter.
- The five-year high for EBT Margin was 27.99% in Q1 2026, with the low at 70.34% in Q2 2025.
- The 5-year median for EBT Margin is 6.08% (2023), against an average of 0.05%.
- The sharpest annual moves came in 2023 and 2025: EBT Margin soared 4105 bps in 2023, then plunged 8381 bps in 2025.
- Jazz Pharmaceuticals' EBT Margin stood at 34.97% in 2022, then jumped by 117 bps to 6.08% in 2023, then soared by 101 bps to 12.24% in 2024, then surged by 42 bps to 17.4% in 2025, then surged by 61 bps to 27.99% in 2026.
- Business Quant data shows JAZZ's EBT Margin at 27.99% in Q1 2026, 17.4% in Q4 2025, and 0.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 17.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.46% |
| Mar 31, 2026 | 27.99% |
| Dec 31, 2025 | 17.40% |
| Sep 30, 2025 | 0.80% |
| Jun 30, 2025 | -70.34% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 19.03% |
| Jun 30, 2024 | 13.47% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | 6.08% |
| Sep 30, 2023 | 10.24% |
| Jun 30, 2023 | 8.54% |
| Mar 31, 2023 | 6.17% |
| Dec 31, 2022 | -34.97% |
| Sep 30, 2022 | -6.39% |
| Jun 30, 2022 | 2.25% |
| Mar 31, 2022 | 0.78% |
| Dec 31, 2021 | -5.00% |
| Sep 30, 2021 | -8.07% |